We reviewed the safety and efficacy of overnight closed-loop insulin delivery compared with conventional continuous subcutaneous insulin infusion (CSII) in two distinct age groups with type 1 diabetes mellitus (T1DM), young people aged 5 to 18 years and adults, combining data of previously published randomized studies.
Methods:
We evaluated four randomized crossover studies in 17 children and adolescents [13.4 ± 3.6 years; mean ± standard deviation (SD)] and 24 adults (37.5 ± 9.1 years) on 45 closed-loop (intervention) and 45 CSII (control) visits. Each subject attended for two overnight study visits, using either closed-loop or conventional pump therapy, in random order. In each age group, studies were designed to mimic realistic likely scenarios. In the children and adolescent studies, closed loop was used following a standard evening meal and following 40 min of moderate-intensity exercise. In the adult studies, closed loop was commenced following a 60 g carbohydrate meal or a 100 g carbohydrate meal accompanied by alcohol. The primary outcome measure was time for which plasma glucose was within target range (3.91–8.0 mmol/liter).
Results:
Overnight closed loop increased the time in target plasma glucose in both young (from 40% to 60%, p = .002) and adults (from 50% to 76%, p < .001) compared with conventional CSII. Combined analysis showed an increase from 43% to 71% with closed loop (p < .001). Additionally, closed loop reduced the time spent below 3.91 mmol/liter and above 8.0 mmol/liter, from 4.1% to 2.1% (p = .01) and 33% to 20% (p = .03), respectively. Glycemic variability, as measured by the SD of plasma glucose, was lower during closed loop compared with CSII (1.5 versus 2.1 mmol/liter, p = .007).
Conclusions:
Overnight closed loop may improve glycemic control and reduce nocturnal hypoglycemia in both young people and adults with T1DM.
KleinBEKleinRMcBridePECruickshanksKJPaltaMKnudtsonMDMossSEReinkeJO. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med.2004;164 (17): 1917–24.
2.
NathanDMClearyPABacklundJYGenuthSMLachinJMOrchardTJRaskinPZinmanB; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med.2005;353 (25): 2643–53.
3.
WhiteNHSunWClearyPADanisRPDavisMDHainsworthDPHubbardLDLachinJMNathanDM. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol.2008;126 (12): 1707–15.
4.
The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes.1997;46 (2): 271–86.
5.
WildDvon MaltzahnRBrohanEChristensenTClausonPGonder-FrederickL. A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns.2007;68 (1): 10–5.
6.
WeberCSchnellO. The assessment of glycemic variability and its impact on diabetes-related complications: An overview. Diabetes Technol Ther.2009;11 (10): 623–33.
7.
BruttomessoDCostaSBaritussioA. Continuous subcutaneous insulin infusion (CSII) 30 years later: Still the best option for insulin therapy. Diabetes Metab Res Rev.2009;25 (2): 99–111.
8.
HirschIBArmstrongDBergenstalRMBuckinghamBChildsBPClarkeWLPetersAWolpertH. Clinical application of emerging sensor technologies in diabetes management: Consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther.2008;10 (4): 232–46.
9.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. New Engl J Med.2008;359 (14): 1464–76.
10.
The DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med.1991;90 (4): 450–9.
11.
DavisEAKeatingBByrneGCRussellMJonesTW. Hypoglycemia: Incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care.1997;20 (1): 22–5.
12.
AminRRossKAceriniCLEdgeJAWarnerJDungerDB. Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: Use of continuous glucose monitoring system. Diabetes Care.2003;26 (3): 662–7.
13.
BergenstalRMTamborlaneWVAhmannABuseJBDaileyGDavisSNJoyceCPeoplesTPerkinsBAWelshJBWilliSMWoodMA; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. New Engl J Med.2010;363 (4): 311–20.
HovorkaR. Closed-loop insulin delivery: From bench to clinical practice. Nat Rev Endocrinol.2011;7 (7): 385–95.
16.
KumareswaranKEvansMLHovorkaR. Artificial Pancreas: An emerging approach to treat type 1 diabetes. Expert Rev Med Devices.2009;6 (4): 401–10.
17.
HovorkaRKumareswaranKHarrisJAllenJMElleriDXingDKollmanCNodaleMMurphyHRDungerDBAmielSAHellerSRWilinskaMEEvansML. Overnight closed loop insulin delivery (Artificial Pancreas) in adults with type 1 diabetes: Crossover randomised controlled studies. BMJ.2011;342: d1855.
18.
HovorkaRAllenJMElleriDChassinLJHarrisJXingDKollmanCHovorkaTLarsenAMNodaleMDe PalmaAWilinskaMEAceriniCLDungerDB. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: A phase 2 randomised crossover trial. Lancet.2010;375 (9716): 743–51.
19.
GeoffreyMBrazgRRichardW. FreeStyle Navigator Continuous Glucose Monitoring System with TRUstart algorithm, a 1-hour warm-up time. J Diabetes Sci Technol.2011;5 (1): 99–106.
20.
BrageSEkelundUBrageNHenningsMAFrobergKFranksPWWarehamNJ. Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity. J Appl Physiol.2007;103 (2): 682–92.
21.
HovorkaRShojaee-MoradieFCarrollPVChassinLJGowrieIJJacksonNCTudorRSUmplebyAMJonesRH. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. Am J Physiol Endocrinol Metab.2002;282 (5): E992–1007.
22.
MazorEAverbuchABar-ShalomYDayanJ. Interacting multiple model methods in target tracking: A survey. IEEE Trans Aerospace Electronic Syst.2002;34 (1): 103–23.
23.
KovatchevBPCoxDJGonder-FrederickLAYoung-HymanDSchlundtDClarkeW. Assessment of risk for severe hypoglycemia among adults with IDDM: Validation of the low blood glucose index. Diabetes Care.1998;21 (11): 1870–5.
24.
WilliamsRMDungerDB. Insulin treatment in children and adolescents. Acta Paediatr.2004;93 (4): 440–6.
25.
BrydenKSPevelerRCSteinANeilAMayouRADungerDB. Clinical and psychological course of diabetes from adolescence to young adulthood: A longitudinal cohort study. Diabetes Care.2001;24 (9): 1536–40.
26.
MorrisADBoyleDIMcMahonADGreeneSAMacDonaldTMNewtonRW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet.1997;350 (9090): 1505–10.
27.
ElleriDAceriniCLAllenJMHayesJPesterfieldCWilinskaMEDungerDBHovorkaR. Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes. Diabetes Technol Ther.2010;12 (1): 35–9.
28.
ErtlACDavisSN. Evidence for a vicious cycle of exercise and hypoglycemia in type 1 diabetes mellitus. Diabetes Metab Res Rev.2004;20 (2): 124–30.
29.
ElleriDAllenJKumareswaranKLeelarathnaLNodaleMCaldwellK. Day-and-night closed-loop glucose control in adolescents with type 1 diabetes. Proceedings of the 4th Advanced Technologies and Treatments for Diabetes Conference, February 2011, London, UK.
30.
TurnerBCJenkinsEKerrDSherwinRSCavanDA. The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care.2001;24 (11): 1888–93.
31.
KerrDMacdonaldIAHellerSRTattersallRB. Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with type 1 (insulin-dependent) diabetes. Diabetologia.1990;33 (4): 216–21.
32.
ElleriDAllenJMNodaleMWilinskaMEMangatJSLarsenAMAceriniCLDungerDBHovorkaR. Automated overnight closed-loop glucose control in young children with type 1 diabetes. Diabetes Technol Ther.2011;13 (4): 419–24.
33.
WeinzimerSASteilGMSwanKLDziuraJKurtzNTamborlaneWV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an Artificial Pancreas. Diabetes Care.2008;31 (5): 934–9.
34.
CastleJREngleJMEl YoussefJMassoudRGYuenKCKaganRWardWK. Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care.2010;33 (6): 1282–7.
35.
KovatchevBCobelliCRenardEAndersonSBretonMPatekSClarkeWBruttomessoDMaranACostaSAvogaroAManC DallaFacchinettiAMagniLDe NicolaoGPlaceJFarretA. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: Summary of the results. J Diabetes Sci Technol.2010;4 (6): 1374–81.
36.
AtlasENimriRMillerSGrunbergEAPhillipM. MD-logic Artificial Pancreas system: A pilot study in adults with type 1 diabetes. Diabetes Care.2010;33 (5): 1072–6.
37.
BuckinghamBChaseHPDassauECobryEClintonPGageVCaswellKWilkinsonJCameronFLeeHBequetteBWDoyleFJ3rd. Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care.2010;33 (5): 1013–7.
38.
El-KhatibFHRussellSJNathanDMSutherlinRGDamianoER. A bihormonal closed-loop Artificial Pancreas for type 1 diabetes. Sci Transl Med.2010;2 (27): 27ra27.
39.
PerssonMNormanMHansonU. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: A large, population-based study. Diabetes Care.2009;32 (11): 2005–9.
40.
MurphyHRElleriDAllenJMHarrisJSimmonsDRaymanGTempleRDungerDBHaidarANodaleMWilinskaMEHovorkaR. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care.2011;34 (2): 406–11.
